Prudential Financial’s Impax Laboratories, Inc. IPXL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q2 | – | Sell |
-124,661
| Closed | -$2.42M | – | 2504 |
|
|
2018
Q1 | $2.42M | Buy |
124,661
+2,020
| +2% | +$39.6K | ﹤0.01% | 1501 |
|
|
2017
Q4 | $2.04M | Sell |
122,641
-2,010
| -2% | -$36.8K | ﹤0.01% | 1580 |
|
|
2017
Q3 | $2.53M | Sell |
124,651
-10
| -0% | -$191 | ﹤0.01% | 1468 |
|
|
2017
Q2 | $2.01M | Sell |
124,661
-1,790
| -1% | -$26.4K | ﹤0.01% | 1561 |
|
|
2017
Q1 | $1.6M | Sell |
126,451
-460
| -0.4% | -$5.56K | ﹤0.01% | 1676 |
|
|
2016
Q4 | $1.68M | Sell |
126,911
-7,870
| -6% | -$135K | ﹤0.01% | 1624 |
|
|
2016
Q3 | $3.19M | Sell |
134,781
-315,280
| -70% | -$8.47M | 0.01% | 1282 |
|
|
2016
Q2 | $13M | Buy |
450,061
+285,420
| +173% | +$9.3M | 0.02% | 725 |
|
|
2016
Q1 | $5.27M | Buy |
164,641
+9,500
| +6% | +$334K | 0.01% | 1069 |
|
|
2015
Q4 | $6.63M | Sell |
155,141
-1,700
| -1% | -$67.9K | 0.01% | 959 |
|
|
2015
Q3 | $5.52M | Buy |
156,841
+4,060
| +3% | +$183K | 0.01% | 974 |
|
|
2015
Q2 | $7.02M | Sell |
152,781
-142,000
| -48% | -$6.74M | 0.01% | 963 |
|
|
2015
Q1 | $13.8M | Sell |
294,781
-206,200
| -41% | -$8.2M | 0.02% | 703 |
|
|
2014
Q4 | $15.9M | Buy |
500,981
+239,400
| +92% | +$7.01M | 0.03% | 563 |
|
|
2014
Q3 | $6.2M | Buy |
261,581
+98,414
| +60% | +$2.52M | 0.01% | 859 |
|
|
2014
Q2 | $4.89M | Buy |
163,167
+6,986
| +4% | +$188K | 0.01% | 1009 |
|
|
2014
Q1 | $4.13M | Buy |
156,181
+1,100
| +0.7% | +$27.5K | 0.01% | 1060 |
|
|
2013
Q4 | $3.9M | Sell |
155,081
-300
| -0.2% | -$6.69K | 0.01% | 1103 |
|
|
2013
Q3 | $3.19M | Buy |
155,381
+8,100
| +5% | +$167K | 0.01% | 1156 |
|
|
2013
Q2 | $2.94M | Buy |
+147,281
| New | +$2.61M | 0.01% | 1160 |
|
Prudential Financial's IPXL Position: Q2 2018 in Review
Prudential Financial sold out of Impax Laboratories, Inc. (IPXL) in Q2 2018, closing a stake of 124,661 shares — an estimated $2.42M sold.
Prudential Financial first reported a position in IPXL in Q2 2013 and held it in 20 quarters. The position peaked at $15.9M in Q4 2014. 1 fund tracked by Wall St. Rank holds IPXL as of Q2 2018.
- Prudential Financial reported no remaining Impax Laboratories, Inc. position as of Q2 2018 after selling out during the quarter.
- Prudential Financial sold 124,661 Impax Laboratories, Inc. shares in Q2 2018, an estimated $2.42M.
- Prudential Financial first reported a position in Impax Laboratories, Inc. in Q2 2013 and held it in 20 quarters.
- Prudential Financial's Impax Laboratories, Inc. position peaked at $15.9M in Q4 2014.
- 1 fund tracked by Wall St. Rank held Impax Laboratories, Inc. as of Q2 2018.
Based on Prudential Financial's 13F filing for Q2 2018, filed 13 Aug 2018.